The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 15,577 | 1,437,028 | SH | SOLE | 1,437,028 | 0 | 0 | ||
| ALLENA PHARMACEUTICALS INC | COM | 018119107 | 4,263 | 3,330,373 | SH | SOLE | 3,330,373 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 32,400 | 2,571,450 | SH | SOLE | 2,571,450 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 19,344 | 899,700 | SH | SOLE | 899,700 | 0 | 0 | ||
| APTINYX INC | COM | 03836N103 | 11,038 | 3,190,079 | SH | SOLE | 3,190,079 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 296,569 | 10,542,790 | SH | SOLE | 10,542,790 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 3,898 | 1,296,743 | SH | SOLE | 1,296,743 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 10,227 | 568,500 | SH | SOLE | 568,500 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 18,902 | 943,666 | SH | SOLE | 943,666 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 7,943 | 731,436 | SH | SOLE | 731,436 | 0 | 0 | ||
| FRAZIER LIFESCIENCES ACQU CO | UNIT 12/09/2025 | G3710A121 | 15,580 | 1,501,000 | SH | SOLE | 1,501,000 | 0 | 0 | ||
| FREELINE THERAPEUTICS HLDGS | SPONSORED ADS | 35655L107 | 10,043 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| GALERA THERAPEUTICS INC | COM | 36338D108 | 2,465 | 241,000 | SH | SOLE | 241,000 | 0 | 0 | ||
| GRITSTONE ONCOLOGY INC | COM | 39868T105 | 8,123 | 2,061,758 | SH | SOLE | 2,061,758 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 60,923 | 1,312,999 | SH | SOLE | 1,312,999 | 0 | 0 | ||
| ITERUM THERAPEUTICS PLC | SHS | G6333L101 | 1,521 | 1,538,316 | SH | SOLE | 1,538,316 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 17,237 | 2,494,500 | SH | SOLE | 2,494,500 | 0 | 0 | ||
| KRYSTAL BIOTECH INC | COM | 501147102 | 53,700 | 895,000 | SH | SOLE | 895,000 | 0 | 0 | ||
| MINERVA NEUROSCIENCES INC | COM | 603380106 | 144 | 61,541 | SH | SOLE | 61,541 | 0 | 0 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 62,278 | 3,566,912 | SH | SOLE | 3,566,912 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 7,906 | 841,908 | SH | SOLE | 841,908 | 0 | 0 | ||
| NABRIVA THERAPEUTICS PLC | SHS NEW | G63637113 | 1,030 | 425,650 | SH | SOLE | 425,650 | 0 | 0 | ||
| PASSAGE BIO INC | COM | 702712100 | 128,086 | 5,009,219 | SH | SOLE | 5,009,219 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 193,587 | 5,827,415 | SH | SOLE | 5,827,415 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 15,511 | 341,954 | SH | SOLE | 341,954 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 9,213 | 168,000 | SH | SOLE | 168,000 | 0 | 0 | ||
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 7,449 | 153,500 | SH | SOLE | 153,500 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 3,251 | 202,803 | SH | SOLE | 202,803 | 0 | 0 | ||
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 1,657 | 35,750 | SH | SOLE | 35,750 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 21,741 | 1,001,421 | SH | SOLE | 1,001,421 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 31,248 | 1,405,045 | SH | SOLE | 1,405,045 | 0 | 0 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 79,236 | 1,917,157 | SH | SOLE | 1,917,157 | 0 | 0 | ||
| TRANSLATE BIO INC | COM | 89374L104 | 40,229 | 2,182,789 | SH | SOLE | 2,182,789 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 44,879 | 3,053,107 | SH | SOLE | 3,053,107 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 61,365 | 2,309,554 | SH | SOLE | 2,309,554 | 0 | 0 | ||